Symphogen - PDFSEARCH.IO - Document Search Engine

Symphogen
Results: 16

#	Item
1	January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion ImmunoOncology Deal In yet Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-01-11 11:16:23 Business Biotechnology Economy Pharmacy Pharmaceutical industry Pharmaceuticals policy Biopharmaceutical Pharmaceutical industry in India Novartis Biosimilar Boehringer Ingelheim Teva Pharmaceutical Industries
2	Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology  Partnership aims to advance development of novel immune checkpoint Add to Reading List Source URL: sunstone.eu Language: English - Date: 2016-01-04 04:51:17
3	Symphogen Enters into strategic collaboration with Genentech for antibody therapeutics SYMPHOGEN ENTERS INTO STRATEGIC COLLABORATION WITH GENENTECH FOR ANTIBODY THERAPEUTICS IN INFECTIOUS DISEASE COPENHAGEN, Denmark – Add to Reading List Source URL: sunstone.eu Language: English - Date: 2014-10-27 08:46:29 Glycoproteins Medicine Symphogen Biotechnology Antibody Genentech Monoclonal antibody therapy Polyclonal antibodies John McCafferty Immunology Biology Immune system
4	PDF Document Add to Reading List Source URL: dwl.gov-online.go.jp Language: English - Date: 2013-04-04 10:31:40 Glycoproteins Medicine Antibodies Antigen Immunoglobulin M Biotechnology Symphogen Polyclonal antibodies Immune system Biology Immunology
5	FOR IMMEDIATE RELEASE Theraclone Sciences’ I-‐STAR™ Technology Chosen by Wellcome Trust to Identify Therapeutic Antibodies Against Ebol Add to Reading List Source URL: www.theraclone-sciences.com Language: English - Date: 2015-04-30 08:07:06 Ebola Ebola virus disease Mononegavirales Zoonoses Biologic Antibody Virus Cambridge Antibody Technology Symphogen Biology Medicine Immune system
6	Molecular Engineering The Molecular Engineering laboratory focuses on development and application of Darwinian in vitro selection technologies, allowing the generation of novel recombinant antibodies. Today the global ma Add to Reading List Source URL: eng.au.dk Language: English - Date: 2015-02-02 10:36:34 Immunology Biotechnology Glycoproteins Antibody Biologic Biomarker Monoclonal antibodies Symphogen Biology Medicine Immune system
7	PRESS RELEASE: Bioceros B.V. announces change of ownership Utrecht, The Netherlands, February 17th, Bioceros B.V. announces that it has successfully realized a change of ownership. This is the result of the pu Add to Reading List Source URL: thujacapital.com Language: English - Date: 2011-11-06 02:53:53 Monoclonal antibodies Immune system Medicine Biologic Crucell Symphogen Immunology Biotechnology Biology
8	Advancing the Frontier of Antibody Therapeutics Kirsten Drejer, PhD Chief Executive Officer Add to Reading List Source URL: www.symphogen.com Language: English - Date: 2014-01-14 13:28:11 Bristol-Myers Squibb Cetuximab Tyrosine kinase receptors Immune system Symphogen Monoclonal antibody therapy Monoclonal antibodies HER2/neu Zalutumumab Immunology Biology Medicine
9	MORPHODOMA® Technology: Enhancing Antibody Titers Add to Reading List Source URL: www.morphotek.com Language: English - Date: 2011-02-26 01:00:51 Antibody Monoclonal antibodies B cell Library Antigen Polyclonal antibodies Symphogen Immune system Biology Anatomy
10	[removed]Zymeworks_Merck_Expansion_Extension Add to Reading List Source URL: www.biotech.ca Language: English - Date: 2014-12-09 09:56:32 Biotechnology Medicine Glycoproteins Monoclonal antibody therapy Monoclonal antibodies Merck & Co. Biologic Antibody Symphogen Biology Immune system Immunology

UPDATE